Adline Chem Lab

Adline Chem Lab Debt

Delisted·Sep 16, 2026

The Debt of Adline Chem Lab (524604.BO) as of Nov 21, 2026 is 13.33 M INR. In the previous year, Debt was 13.17 M INR — a change of 1.24% (higher).

Debt

13.33 MINR

YoY

1.24%

Last updated:

In 2023, Adline Chem Lab's total debt was 13.33 M INR, a 1.24% change from the 13.17 M INR total debt recorded in the previous year.

The Adline Chem Lab Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2021
25.02 M INR
Jan 1, 2022
13.17 M INR
Jan 1, 2023
13.33 M INR
The Adline Chem Lab Debt history
YEARDebtYoY
13.33 MINR+1.24%
13.17 MINR-47.36%
25.02 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adline Chem Lab Stock analysis

What does Adline Chem Lab do? Adline Chem Lab Ltd. manufactures pharmaceutical products for domestic and international markets. The company's domestic product lines include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care, and hepatocare. For international markets, the firm offers tablets, capsules, and injections. Veterinary products such as B Complex Liver Extract With Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP, and Tetracyclin-bolus Tablets are sold to veterinary clients. Educational supplements like Demo-Dose Dyaz, Demo-dose colac, Demo-Dose Dilat, and Demo-Eose eryth target healthcare professionals for product demonstration purposes. The domestic market segments purchase pharmaceuticals for human health needs, while international buyers acquire tablets, capsules, and injections for global distribution. Veterinary clients specifically buy the listed veterinary products for animal health applications. Educational supplements are purchased by healthcare professionals to demonstrate product efficacy during training sessions. Adline Chem Lab Ltd. generates revenue through the sale of pharmaceutical products to domestic consumers, international distributors, veterinary practices, and healthcare professionals. The company's domestic market focuses on human health solutions, while international sales emphasize standardized dosage forms. Veterinary product sales cater to animal health sectors, and educational supplements support product education within the medical community. Adline Chem Lab is one of the most popular companies on Eulerpool.

Debt Details

Understanding Adline Chem Lab's Debt Structure

Adline Chem Lab's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Adline Chem Lab's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Adline Chem Lab’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Adline Chem Lab’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Adline Chem Lab stock

Debt of Adline Chem Lab is 13.33 M INR in 2023.

Debt of Adline Chem Lab changed from 13.17 M INR to 13.33 M INR, representing a 1.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Adline Chem Lab since 2006 – with annual values, charts, and detailed analysis.

Debt's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Adline Chem Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Adline Chem Lab

All Key Metrics — Adline Chem Lab